Literature DB >> 10556538

Impact of cryopreservation on B cell chronic lymphocytic leukaemia phenotype.

V Deneys1, V Thiry, N Hougardy, A M Mazzon, P Leveugle, M De Bruyère.   

Abstract

BACKGROUND AND OBJECTIVES: Freezing is a practical approach for cell preservation for retrospective studies. The aim of this work was to check the cryopreservation impact on B cell chronic lymphocytic leukaemia phenotype.
MATERIAL AND METHODS: Blood samples from 15 CLL patients were analyzed freshly and after freezing at -196 degrees C, without separation, and thawing. Results were compared by Student's paired t-test.
RESULTS: The phenotype of fresh CLL cells was as follows: CD19+, CD5+, faint CD20, CD23+/-, weak CD22 and sIg, CD37+, HLA-DR+, FMC7-. After cryopreservation, the percentage of CD5 and CD23 positive cells decreased, whereas HLA-DR positive cells increased moderately. The CLL Matutes's score was modified in 6 cases out of 15 (40%).
CONCLUSION: Cryopreservation modifies B cell chronic lymphocytic leukaemia phenotype, by decreasing CD5 and CD23 expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556538     DOI: 10.1016/s0022-1759(99)00089-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentration.

Authors:  Michael A Sheard; Matthew V Ghent; Daniel J Cabral; Joanne C Lee; Vazgen Khankaldyyan; Lingyun Ji; Samuel Q Wu; Min H Kang; Richard Sposto; Shahab Asgharzadeh; C Patrick Reynolds
Journal:  Exp Cell Res       Date:  2015-04-03       Impact factor: 3.905

2.  Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease.

Authors:  Mareike Florek; Dominik Schneidawind; Antonio Pierini; Jeanette Baker; Randall Armstrong; Yuqiong Pan; Dennis Leveson-Gower; Robert Negrin; Everett Meyer
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

Review 3.  Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation.

Authors:  Giuseppe V Masucci; Alessandra Cesano; Rachael Hawtin; Sylvia Janetzki; Jenny Zhang; Ilan Kirsch; Kevin K Dobbin; John Alvarez; Paul B Robbins; Senthamil R Selvan; Howard Z Streicher; Lisa H Butterfield; Magdalena Thurin
Journal:  J Immunother Cancer       Date:  2016-11-15       Impact factor: 13.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.